NEOGEN CORP false 0000711377 0000711377 2022-11-30 2022-11-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 30, 2022

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

Michigan |  | 0-17988 |  | 38-2367843
(State or other jurisdiction of incorporation) |  | (Commission File Number) |  | (IRS Employer Identification No.)

620 Lesher Place Lansing, Michigan |  | 48912
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code 517-372-9200

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of each Class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, $0.16 par value per share |  | NEOG |  | NASDAQ Global Select Market

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. | Regulation FD Disclosure.

On November 30, 2022 Neogen Corporation (“Neogen”) presented an update of its business, including the recent combination of Neogen and the Food Safety business of 3M Company, at the Piper Sandler Healthcare Conference. Also on November 30, 2022, Neogen issued an investor presentation in connection with its business update. A copy of the investor presentation is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 | Financial Statements and Exhibits

(d) Exhibits

99.1 |  | Investor Presentation dated November 30, 2022
104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  |  |  |  |  | NEOGEN CORPORATION
|  |  |  |  |  | (Registrant)
Date: November 30, 2022 |  |  |  |  |  | /s/ Steven J. Quinlan
|  |  |  |  |  | Steven J. Quinlan
|  |  |  |  |  | Vice President & CFO